Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. MYND Lifesciencs Inc.
  6. Summary
    MYND   CA62857B1094

MYND LIFESCIENCS INC.

(MYND)
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Canadian National Stock E…
10/12/2021 10/13/2021 10/18/2021 10/19/2021 10/22/2021 Date
0.65(c) 0.7(c) 0(c) 0.9(c) 0.85(c) Last
9 500 3 000 100 3 275 1 698 Volume
-2.99% +7.69% -100.00% -5.56% Change
More quotes
Estimated financial data (e)
Sales 2019 - - -
Net income 2019 -0,00 M -0,00 M -0,00 M
Net Debt 2019 - - -
P/E ratio 2019 -
Yield 2019 -
Sales 2020 - - -
Net income 2020 -0,00 M -0,00 M -0,00 M
Net Debt 2020 - - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 39,0 M 31,6 M 31,5 M
Capi. / Sales 2019 -
Capi. / Sales 2020 -
Nbr of Employees 10
Free-Float -
More Financials
Company
Sector
-
Calendar
12/20Shareholder meeting
More about the company
All news about MYND LIFESCIENCS INC.
10/18KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Vie..
AQ
10/11KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
AQ
10/07MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidi..
CI
09/29MYND LIFE SCIENCES INC : . Announces RSU Grant
AQ
09/09MYND Lifesciencs Inc. announced that it has received CAD 2.7 million in funding
CI
08/26MYND LIFESCIENCS : Life Sciences Announces $3 Million Convertible Debenture Unit Offering
AQ
08/26MYND Lifesciencs Inc. announced that it expects to receive CAD 3 million in funding
CI
08/11MYND LIFESCIENCS : Life Sciences Announces DTC Eligibility
AQ
06/23MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer's disease
CI
06/17MYND Life Sciences Announces LOI with Eyam Vaccines and Immunotherapeutics
CI
06/15MYND LIFESCIENCS : Life Sciences to Present at H.C. Wainwright Psychedelics in Psychiatry ..
AQ
06/10MYND LIFESCIENCS : Life Sciences Announces Patent Applications for Depression and Neuropsy..
AQ
06/10MYND Lifesciencs Inc. Announces Patent Applications for Depression and Neuropsychiatric..
CI
06/01MYND Life Sciences Announces Depression Biomarker Diagnostic Program
CI
06/01MYND LIFESCIENCS : Life Sciences announces Depression Biomarker Diagnostic Program
AQ
More news
News in other languages on MYND LIFESCIENCS INC.

- No features available -

More news
Chart MYND LIFESCIENCS INC.
Duration : Period :
MYND Lifesciencs Inc. Technical Analysis Chart | MYND | CA62857B1094 | MarketScreener
Income Statement Evolution
Managers and Directors
Lyle Oberg Chief Executive Officer & Director
Paul Ciullo Chief Financial Officer & Secretary
Wilfred A. Jefferies Chairman & Chief Science Officer
Jordan Cleland Chief Operating Officer
Aaron Bowden Independent Director